Legend Biotech Corp Adr (LEGN)

Mar 17, 2025

Legend Biotech’s SWOT analysis: carvykti’s strong efficacy drives stock outlook - Investing.com

Mar 17, 2025

Mar 13, 2025

Piper Sandler maintains Overweight on Legend Biotech, $78 target By Investing.com - Investing.com South Africa

Mar 13, 2025

Mar 12, 2025

RBC Capital maintains Outperform rating on Legend Biotech shares - Investing.com

Mar 12, 2025

Mar 12, 2025

RBC Capital maintains Outperform rating on Legend Biotech shares By Investing.com - Investing.com South Africa

Mar 12, 2025

Mar 12, 2025

BMO Capital maintains Legend Biotech at Outperform with $90 target - Investing.com

Mar 12, 2025

Mar 12, 2025

BMO Capital maintains Legend Biotech at Outperform with $90 target By Investing.com - Investing.com UK

Mar 12, 2025

Mar 12, 2025

Piper Sandler maintains Overweight on Legend Biotech, $78 target - Investing.com India

Mar 12, 2025

Mar 12, 2025

Legend Biotech stock price target raised to $75 at H.C. Wainwright - Investing.com India

Mar 12, 2025

Mar 11, 2025

Legend Biotech reports Q4 earnings beat, revenue tops estimates By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 11, 2025

Legend Biotech reports Q4 earnings beat, revenue tops estimates - Investing.com India

Mar 11, 2025

Mar 11, 2025

Earnings call transcript: Legend Biotech Q4 2024 sees strong CARVICTI growth By Investing.com - Investing.com South Africa

Mar 11, 2025

Mar 11, 2025

Earnings call transcript: Legend Biotech Q4 2024 sees strong CARVICTI growth - Investing.com India

Mar 11, 2025

Mar 11, 2025

Compared to Estimates, Legend Biotech (LEGN) Q4 Earnings: A Look at Key Metrics - Yahoo

Mar 11, 2025

Feb 28, 2025

Legend Biotech CorpADR to Host Earnings Call - ACCESS Newswire

Feb 28, 2025

Feb 13, 2025

Arcutis Biotherapeutics (ARQT) Surges 15.9%: Is This an Indication of Further Gains? - Yahoo Finance

Feb 13, 2025

Feb 11, 2025

Market Momentum: Aptargroup Inc (ATR) Registers a 0.07 Increase, Closing at 143.28 - The Dwinnex

Feb 11, 2025

Feb 10, 2025

Legend Biotech Corp ADR (LEGN) rating initates by Redburn Atlantic - Knox Daily

Feb 10, 2025

Feb 10, 2025

A Guide To The Risks Of Investing In Worksport Ltd (WKSP) - Knox Daily

Feb 10, 2025

Feb 06, 2025

Legend Biotech Corp ADR (LEGN) stock analysis: A comprehensive overview - US Post News

Feb 06, 2025

Feb 04, 2025

Beyond Meat Inc (BYND)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Deeper Dive: Understanding Legend Biotech Corp ADR (LEGN) Through its Various Ratios - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Legend Biotech Corp ADR (LEGN) looking to reclaim success with recent performance - SETE News

Feb 04, 2025

Feb 04, 2025

CIMG Inc (IMG)’s Ratio Roundup: Key Metrics for Trailing Twelve Months - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Ratio Analysis: Unpacking XPLR Infrastructure LP (XIFR)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025

Feb 04, 2025

Ratios in Focus: Analyzing Aurora Mobile Ltd ADR (JG)’s Price-to-Cash and Price-to-Free Cash Flow - The Dwinnex

Feb 04, 2025

Feb 03, 2025

Analyze Legend Biotech Corp ADR (NASDAQ: LEGN) Before Investing. - Stocks Register

Feb 03, 2025

Jan 28, 2025

Legend Biotech's SWOT analysis: carvykti's efficacy drives stock potential amid competition - Investing.com India

Jan 28, 2025

Jan 27, 2025

Barclays lifts Johnson & Johnson stock target to $166 - Investing.com

Jan 27, 2025

Jan 24, 2025

Strength Seen in Eton Pharmaceuticals (ETON): Can Its 10.8% Jump Turn into More Strength? - Yahoo Finance

Jan 24, 2025

Jan 22, 2025

Legend Biotech stock target cut to $91 by Jefferies - Investing.com South Africa

Jan 22, 2025

Jan 21, 2025

Legend Biotech keeps stock at Buy rating on strong position - Investing.com India

Jan 21, 2025

Jan 20, 2025

When will lagging health care stocks return to healthy growth? - The Globe and Mail

Jan 20, 2025

Jan 16, 2025

Legend Biotech's SWOT analysis: carvykti's strong sales fuel stock's potential - Investing.com India

Jan 16, 2025

Jan 16, 2025

Legend Biotech's SWOT analysis: carvykti's strong sales fuel stock's potential By Investing.com - Investing.com South Africa

Jan 16, 2025

Jan 09, 2025

With BIOSECURE in limbo, should BeiGene or Legend sell itself in 2025? Analysts weigh in - Fierce Pharma

Jan 09, 2025

Jan 08, 2025

Legend Biotech's SWOT analysis: carvykti sales boost stock amid competition - Investing.com India

Jan 08, 2025

Dec 30, 2024

Legend Biotech's SWOT analysis: carvykti's promise drives stock outlook By Investing.com - Investing.com South Africa

Dec 30, 2024

Dec 30, 2024

Legend Biotech's SWOT analysis: carvykti's promise drives stock outlook - Investing.com India

Dec 30, 2024

Dec 30, 2024

Overweight rating for Legend Biotech reflects confidence in long-term CARVYKTI revenue - Investing.com India

Dec 30, 2024

Dec 19, 2024

Legend Biotech stock hits 52-week low at $32.65 amid market challenges - Investing.com

Dec 19, 2024

Dec 15, 2024

Legend Biotech's SWOT analysis: carvykti's efficacy drives stock potential amid challenges - Investing.com India

Dec 15, 2024

Dec 12, 2024

Legend Biotech stock hits 52-week low at $36.9 amid market shifts By Investing.com - Investing.com South Africa

Dec 12, 2024

Dec 11, 2024

Legend Biotech stock hits 52-week low at $36.9 amid market shifts - Investing.com

Dec 11, 2024

Dec 03, 2024

Analysts Expect ACWI To Hit $136 - Nasdaq

Dec 03, 2024